Total Payments
$666,456
2024 Payments
$110,092
Companies
31
Transactions
554
Medicare Patients
782
Medicare Billing
$137,472
Payment Breakdown by Category
Consulting$318,275 (47.8%)
Other$283,793 (42.6%)
Travel$47,915 (7.2%)
Food & Beverage$16,367 (2.5%)
Education$106.55 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $318,275 | 137 | 47.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $276,468 | 99 | 41.5% |
| Travel and Lodging | $47,915 | 90 | 7.2% |
| Food and Beverage | $16,367 | 217 | 2.5% |
| Honoraria | $7,325 | 6 | 1.1% |
| Education | $106.55 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $207,513 | 153 | $0 (2024) |
| Merck Sharp & Dohme LLC | $113,608 | 79 | $0 (2024) |
| Clovis Oncology, Inc. | $75,485 | 66 | $0 (2022) |
| Eisai Inc. | $65,428 | 59 | $0 (2024) |
| GlaxoSmithKline, LLC. | $37,603 | 28 | $0 (2024) |
| AstraZeneca UK Limited | $24,041 | 10 | $0 (2024) |
| Seagen Inc. | $18,903 | 19 | $0 (2023) |
| ABBVIE INC. | $16,536 | 13 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $15,332 | 17 | $0 (2022) |
| Genmab U.S., Inc. | $12,935 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110,092 | 90 | Merck Sharp & Dohme LLC ($34,782) |
| 2023 | $115,388 | 91 | Merck Sharp & Dohme LLC ($37,779) |
| 2022 | $78,409 | 61 | AstraZeneca Pharmaceuticals LP ($34,809) |
| 2021 | $63,297 | 43 | AstraZeneca Pharmaceuticals LP ($19,287) |
| 2020 | $65,842 | 50 | AstraZeneca Pharmaceuticals LP ($20,964) |
| 2019 | $101,929 | 98 | AstraZeneca Pharmaceuticals LP ($52,498) |
| 2018 | $60,160 | 65 | AstraZeneca Pharmaceuticals LP ($21,030) |
| 2017 | $71,338 | 56 | AstraZeneca Pharmaceuticals LP ($36,297) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| 11/20/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $4,110.00 | General |
| 11/20/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $6,710.00 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,490.00 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/13/2024 | BeiGene USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 11/13/2024 | BeiGene USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 11/12/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 11/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $48.00 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $45.98 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $288.33 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $247.47 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $208.75 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $48.00 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $45.98 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $729.24 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $388.27 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $247.47 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 198 | 431 | $176,832 | $40,124 |
| 2022 | 5 | 198 | 394 | $136,123 | $34,612 |
| 2021 | 5 | 228 | 415 | $150,791 | $39,053 |
| 2020 | 4 | 158 | 368 | $120,522 | $23,683 |
Total Patients
782
Total Services
1,608
Medicare Billing
$137,472
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 35 | 125 | $59,554 | $14,284 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 86 | $40,894 | $9,288 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 91 | $31,927 | $6,926 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 62 | $21,590 | $4,420 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 38 | $9,424 | $2,476 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $10,107 | $2,086 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $3,336 | $643.34 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 31 | 85 | $36,890 | $9,751 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 71 | $30,814 | $8,233 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 68 | $20,060 | $5,054 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 52 | $15,340 | $3,783 | 24.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 60 | $14,880 | $3,548 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $9,775 | $2,529 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 27 | $5,508 | $1,158 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 14 | $2,856 | $555.53 | 19.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 30 | 96 | $42,464 | $11,949 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 58 | 108 | $34,473 | $7,933 | 23.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 49 | $21,490 | $6,073 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 61 | $18,814 | $5,129 | 27.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $10,784 | $2,802 | 26.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $6,705 | $1,829 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 27 | $6,228 | $1,623 | 26.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 18 | $3,861 | $966.62 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 27 | $5,972 | $748.85 | 12.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 60 | 213 | $70,089 | $13,110 | 18.7% |
About Dr. Ramez Eskander, M.D
Dr. Ramez Eskander, M.D is a Obstetrics & Gynecology healthcare provider based in Encinitas, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1144486929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramez Eskander, M.D has received a total of $666,456 in payments from pharmaceutical and medical device companies, with $110,092 received in 2024. These payments were reported across 554 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($318,275).
As a Medicare-enrolled provider, Eskander has provided services to 782 Medicare beneficiaries, totaling 1,608 services with total Medicare billing of $137,472. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location Encinitas, CA
- Active Since 07/31/2008
- Last Updated 11/13/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1144486929
Products in Payments
- LYNPARZA (Drug) $194,363
- Rubraca (Drug) $75,221
- Lenvima (Drug) $59,501
- ZEJULA (Drug) $25,330
- KEYTRUDA (Biological) $20,759
- ELAHERE (Drug) $17,190
- TIVDAK (Drug) $12,672
- TIVDAK (Biological) $12,016
- Avastin (Biological) $11,016
- JEMPERLI (Biological) $8,000
- myChoice CDx (Device) $6,007
- Elahere (Biological) $5,254
- MYCHOICE CDX (Device) $5,125
- PreciseTumor (Device) $4,200
- BAVENCIO (Drug) $4,161
- Fyarro (Drug) $3,106
- Korlym (Drug) $2,018
- KISQALI (Drug) $1,722
- IMFINZI (Biological) $1,431
- Tecentriq (Biological) $760.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Encinitas
Samina Makani, Md, MD
Obstetrics & Gynecology — Payments: $10,614
Obstetrics & Gynecology $10,614
Chandra Spring-Robinson, Do, DO
Obstetrics & Gynecology — Payments: $6,804
Obstetrics & Gynecology $6,804
Dr. Einat Duhamel, M.d, M.D
Obstetrics & Gynecology — Payments: $4,105
Obstetrics & Gynecology $4,105
Dr. Sieu Truong, M.d, M.D
Obstetrics & Gynecology — Payments: $3,906
Obstetrics & Gynecology $3,906
Dr. Lily Tsai, Md, MD
Obstetrics & Gynecology — Payments: $3,408
Obstetrics & Gynecology $3,408
Dr. Dina Fainman, Md, MD
Obstetrics & Gynecology — Payments: $3,043
Obstetrics & Gynecology $3,043